Original language | English |
---|---|
Pages (from-to) | 431-444 |
Number of pages | 14 |
Journal | Critical care medicine |
Volume | 51 |
Issue number | 4 |
DOIs | |
State | Published - Apr 1 2023 |
Keywords
- Critical Care Medicine journal
- Surviving Sepsis Campaign
- guidelines
- history
- methodology
- sepsis
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Critical care medicine, Vol. 51, No. 4, 01.04.2023, p. 431-444.
Research output: Contribution to journal › Article › peer-review
TY - JOUR
T1 - Surviving Sepsis Campaign
AU - Dellinger, R. Phillip
AU - Rhodes, Andrew
AU - Evans, Laura
AU - Alhazzani, Waleed
AU - Beale, Richard
AU - Jaeschke, Roman
AU - Machado, Flavia R.
AU - Masur, Henry
AU - Osborn, Tiffany
AU - Parker, Margaret M.
AU - Schorr, Christa
AU - Townsend, Sean R.
AU - Levy, Mitchell M.
N1 - Funding Information: Although unrestricted, the industry funding that supported the initial years of the SSC (with the majority coming from Eli Lilly and Co and lesser amounts from Baxter and Edwards) became a focus for criticism, reaching an apotheosis when Eichacker et al () in the New England Journal of Medicine opined the whole enterprise gave the appearance of a Lilly-funded marketing exercise. Despite the safeguards that had been put in place to isolate industry funding from decisions on recommendations and carefully scrutinize for COI, these criticisms emphasized the need to put the SSC’s funding, governance, and COI management beyond reproach. Based on these criticisms, a decision was made by the administering organizations to no longer accept industry funding. Funding was transitioned to the administering professional societies and a series of grants from the Gordon and Betty Moore Foundation. In the spirit of this decision, the ISF (which receives industry funding) stepped away from serving as an administering organization. The 2008 guidelines and forward were accomplished without any industry funding. Funding Information: Dr. Rhodes disclosed that he is the chair of the Surviving Sepsis Campaign (SSC) steering committee and has been a past guideline chair. Dr. Levy is a past co-chair of the SSC steering committee. Drs. Dellinger, Evans, and Masur are past SSC guidelines chairs or co-chairs. Drs. Dellinger, Beale, and Schorr are past members of the SSC steering committee. Dr. Beale’s institution received funding from Philips Medical. Dr. Masur disclosed government work. Dr. Osborn received funding from Inflammatix, Beckman, Northwest Anesthesia Seminars, and Baxter. Dr. Townsend reports that he has been a national measure steward for the Centers for Medicare & Medicaid’ Services Early Management Bundle (SEP-1) since 2015. All authors have been members of the SSC guidelines committee.
PY - 2023/4/1
Y1 - 2023/4/1
KW - Critical Care Medicine journal
KW - Surviving Sepsis Campaign
KW - guidelines
KW - history
KW - methodology
KW - sepsis
UR - http://www.scopus.com/inward/record.url?scp=85150395365&partnerID=8YFLogxK
U2 - 10.1097/CCM.0000000000005804
DO - 10.1097/CCM.0000000000005804
M3 - Article
C2 - 36928012
AN - SCOPUS:85150395365
SN - 0090-3493
VL - 51
SP - 431
EP - 444
JO - Critical care medicine
JF - Critical care medicine
IS - 4
ER -